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When Marshall and Warren became laureates of the Nobel
Prize in Medicine, it was emphasized that careful observation,
even at the turn of the 20th Century, could lead to a great dis-
covery with a tremendous impact on public health. This was
also the start of an exploration aiming to ﬁnd the ecological
niche (i.e. the mucus of the digestive tract) and the acknowl-
edgement of Helicobacter pylori indeed being foremost in an
important group of bacteria (i.e. microaerobic and asaccharo-
lytic in nature), which has now been classiﬁed in the Epsilon
branch of Proteobacteria with the Campylobacteraceae. It turns
out that most animals have their own Helicobacter species in
the gut and that some of these can also be transmitted to
humans, leading to short-term infections of the stomach, e.g.
the species forming the Helicobacter heilmannii cluster, or of
the intestine, e.g. Helicobacter pullorum and its possible implica-
tion in inﬂammatory bowel diseases and hepatic disease.
Another aspect of this unusual bug is the amount of
research that has been dedicated to understanding its physi-
ology, pathological mechanisms and epidemiology. Looking at
PubMed, more than 26 600 articles have been published on
this topic, ranking this bacterium as the ﬁfth highest with
respect to number of citations after Escherichia coli, Staphylo-
coccus aureus, Mycobacterium tuberculosis and Pseudomas aeru-
ginosa, despite its recent discovery.
What we want to highlight in this theme section is the
contribution of some of the studies of this bacterium to the
progress of our knowledge in biology and medicine in gen-
eral. The model of Helicobacter infection comprises an excel-
lent example to consider when unravelling the mysteries of
carcinogenesis. MicroRNAs are known to be important in
the regulation of post-transcriptional gene expression. Their
role is presented by Belair et al. who also discuss data that
opened the ﬁeld to H. pylori-induced carcinogenesis.
It is indeed thanks to the model of Helicobacter infection
that Houghton et al. discovered the possible role of stem cells
in gastric carcinoma. Although, previously, we were ignorant
of the tumour-initiating cell, we can now focus our efforts on
this target cell to attempt to elucidate the process that causes
a stem cell to transform into a cancer cell. Again, Helicobacter
is a key element in this evolution, as discussed by Stoicov et al.
The study of H. pylori has also beneﬁtted from new tech-
nologies. Although it was the third bacterium to have its gen-
ome sequenced, important data can now be obtained using
massive sequencing methods; Engstrand presents his results
and projects in this context.
H. pylori is the Helicobacter linked to humans. There are
hypotheses that it evolved in mammals from an ancestral
bacterium living in the primitive gut and, when the stomach
appeared 350 million years ago, some Helicobacters adapted
to this new niche by acquiring the capacity to live in an acidic
environment. Therefore, H. pylori is one of the few known
bacteria that has been following humans via transmission
from generation to generation since the early days when
modern humans moved ‘out of Africa’. The application of
genotyping methods, in particular multilocus sequence typing,
has allowed researchers to trace human migrations. These
data, which appear to be more robust than those previously
published based on the host genes and languages, are
presented by Yamaoka, bringing us far from medicine, but
deep into the fundamental questions regarding human
evolution.
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